Ulviye Acar Çevik

2.2k total citations
101 papers, 1.7k citations indexed

About

Ulviye Acar Çevik is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Ulviye Acar Çevik has authored 101 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Organic Chemistry, 36 papers in Pharmacology and 32 papers in Molecular Biology. Recurrent topics in Ulviye Acar Çevik's work include Synthesis and biological activity (68 papers), Computational Drug Discovery Methods (27 papers) and Cholinesterase and Neurodegenerative Diseases (27 papers). Ulviye Acar Çevik is often cited by papers focused on Synthesis and biological activity (68 papers), Computational Drug Discovery Methods (27 papers) and Cholinesterase and Neurodegenerative Diseases (27 papers). Ulviye Acar Çevik collaborates with scholars based in Türkiye, India and Cyprus. Ulviye Acar Çevik's co-authors include Yusuf Özkay, Zafer Asım Kaplancıklı, Begüm Nurpelin Sağlık, Serkan Levent, Derya Osmani̇ye, Betül Kaya Çavuşoğlu, Sinem Ilgın, İsmail Çeli̇k, Özlem Atlı and Ümide Demir Özkay and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Ulviye Acar Çevik

95 papers receiving 1.7k citations

Peers

Ulviye Acar Çevik
Derya Osmani̇ye Türkiye
Serkan Levent Türkiye
Begüm Nurpelin Sağlık Türkiye
Leyla Yurttaş Türkiye
Hamed I. Ali Egypt
Mohamed M. Abdalla Egypt
Carmen Terán Spain
Khaled R.A. Abdellatif Egypt
Yong Deng China
Ratchanok Pingaew Thailand
Derya Osmani̇ye Türkiye
Ulviye Acar Çevik
Citations per year, relative to Ulviye Acar Çevik Ulviye Acar Çevik (= 1×) peers Derya Osmani̇ye

Countries citing papers authored by Ulviye Acar Çevik

Since Specialization
Citations

This map shows the geographic impact of Ulviye Acar Çevik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulviye Acar Çevik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulviye Acar Çevik more than expected).

Fields of papers citing papers by Ulviye Acar Çevik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulviye Acar Çevik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulviye Acar Çevik. The network helps show where Ulviye Acar Çevik may publish in the future.

Co-authorship network of co-authors of Ulviye Acar Çevik

This figure shows the co-authorship network connecting the top 25 collaborators of Ulviye Acar Çevik. A scholar is included among the top collaborators of Ulviye Acar Çevik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulviye Acar Çevik. Ulviye Acar Çevik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evren, Asaf Evrim, A. Karakaya, Derya Osmani̇ye, et al.. (2025). Latest developments in small molecule analgesics: heterocyclic scaffolds I. Future Medicinal Chemistry. 17(15). 1899–1918. 3 indexed citations
2.
Bostancı, Hayrani Eren, Mehmet Taha Yıldız, Özen Özensoy Güler, et al.. (2025). New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies. Archiv der Pharmazie. 358(3). e2400930–e2400930.
3.
Osmani̇ye, Derya, Begüm Nurpelin Sağlık, Serkan Levent, et al.. (2024). Design, Synthesis, and Biological Effect Studies of Novel Benzofuran–Thiazolylhydrazone Derivatives as Monoamine Oxidase Inhibitors. ACS Omega. 9(10). 11388–11397. 2 indexed citations
4.
Çevik, Ulviye Acar & Tuğba Erçeti̇n. (2023). Design, Synthesis and Evaluation of Pyrrol-thiazole Derivatives as AChE and BuChE Inhibitory and Antioxidant Activities. SHILAP Revista de lepidopterología. 44(4). 625–628. 2 indexed citations
5.
Çevik, Ulviye Acar, Ravikumar Kapavarapu, Kaan Küçükoğlu, et al.. (2023). Design, synthesis and biological evaluation of novel ketone derivatives containing benzimidazole and 1,3,4-triazole as CA inhibitors. Journal of Molecular Structure. 1295. 136770–136770. 7 indexed citations
6.
Karakaya, A., et al.. (2023). Synthesis of thiazole derivatives as cholinesterase inhibitors with antioxidant activity. DergiPark (Istanbul University). 2(3). 118–124. 1 indexed citations
7.
Çevik, Ulviye Acar, et al.. (2023). New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents. Archiv der Pharmazie. 356(5). e2200663–e2200663. 10 indexed citations
8.
Çevik, Ulviye Acar, Asaf Evrim Evren, Hayrani Eren Bostancı, et al.. (2023). Synthesis of Benzimidazole-1,2,4-triazole Derivatives as Potential Antifungal Agents Targeting 14α-Demethylase. ACS Omega. 8(4). 4369–4384. 39 indexed citations
9.
Çevik, Ulviye Acar, İsmail Çeli̇k, Ülküye Dudu Gül, et al.. (2022). Synthesis, and docking studies of novel tetrazole-S-alkyl derivatives as antimicrobial agents. Phosphorus, sulfur, and silicon and the related elements. 198(2). 137–144. 2 indexed citations
10.
Sağlık, Begüm Nurpelin, Ulviye Acar Çevik, Derya Osmani̇ye, et al.. (2020). Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors. Molecules. 25(18). 4342–4342. 9 indexed citations
11.
Çevik, Ulviye Acar, Begüm Nurpelin Sağlık, Derya Osmani̇ye, et al.. (2020). Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 1657–1673. 41 indexed citations
12.
Çavuşoğlu, Betül Kaya, Begüm Nurpelin Sağlık, Ulviye Acar Çevik, et al.. (2020). Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX‐2 inhibitors. Archiv der Pharmazie. 354(3). e2000273–e2000273. 13 indexed citations
13.
Çevik, Ulviye Acar, Begüm Nurpelin Sağlık, Derya Osmani̇ye, et al.. (2020). Synthesis and docking study of benzimidazole–triazolothiadiazine hybrids as aromatase inhibitors. Archiv der Pharmazie. 353(5). e2000008–e2000008. 32 indexed citations
14.
Osmani̇ye, Derya & Ulviye Acar Çevik. (2019). Antifungal Activity of Some Benzimidazole-Hydrazones. SHILAP Revista de lepidopterología. 40(3). 695–699. 1 indexed citations
15.
Çevik, Ulviye Acar, Begüm Nurpelin Sağlık, Serkan Levent, et al.. (2019). Synthesis and AChE-Inhibitory Activity of New Benzimidazole Derivatives. Molecules. 24(5). 861–861. 44 indexed citations
16.
Çevik, Ulviye Acar, et al.. (2018). Synthesis and evaluation of new benzimidazole derivatives with hydrazone moiety as anticancer agents. Turkish Journal of Biochemistry. 43(2). 151–158. 22 indexed citations
17.
Can, Nafiz Öncü, Ulviye Acar Çevik, Begüm Nurpelin Sağlık, et al.. (2017). Pharmacological and Toxicological Screening of Novel Benzimidazole-Morpholine Derivatives as Dual-Acting Inhibitors. Molecules. 22(8). 1374–1374. 19 indexed citations
18.
Çevik, Ulviye Acar, et al.. (2017). Design, Synthesis Molecular Docking Study and Antifungal Activity Evaluation of New Benzimidazole-Triazole Derivatives. SHILAP Revista de lepidopterología. 647–647. 2 indexed citations
19.
Levent, Serkan, Betül Kaya Çavuşoğlu, Begüm Nurpelin Sağlık, et al.. (2017). Synthesis of Oxadiazole-Thiadiazole Hybrids and Their Anticandidal Activity. Molecules. 22(11). 2004–2004. 15 indexed citations
20.
Karaca, Hülya, Ulviye Acar Çevik, Serkan Levent, et al.. (2017). New Benzimidazole-1,2,4-Triazole Hybrid Compounds: Synthesis, Anticandidal Activity and Cytotoxicity Evaluation. Molecules. 22(4). 507–507. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Derya Osmani̇ye Breakdown of academic impact, for papers by Serkan Levent Breakdown of academic impact, for papers by Begüm Nurpelin Sağlık Breakdown of academic impact, for papers by Leyla Yurttaş Breakdown of academic impact, for papers by Hamed I. Ali Breakdown of academic impact, for papers by Mohamed M. Abdalla Breakdown of academic impact, for papers by Carmen Terán Breakdown of academic impact, for papers by Khaled R.A. Abdellatif Breakdown of academic impact, for papers by Yong Deng Breakdown of academic impact, for papers by Ratchanok Pingaew
Rankless by CCL
2026